The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
UiPath Inc. (NYSE:PATH) is one of the cheap AI stocks to buy according to analysts. On April 27, UiPath and Deloitte expanded their collaboration to accelerate software development, testing, and ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leader in agentic business orchestration, today announced the release of agentic AI capabilities on UiPath Automation Suite™. The Automation Suite ...
UiPath, a leader in agentic business orchestration, today announced an expanded collaboration with Deloitte to accelerate software development, testing and deployment for global organisations. This ...
Together, UiPath and Deloitte will help organizations accelerate testing with agentic AI for enhanced resilience and innovation, enabling continuous autonomous quality UiPath (NYSE: PATH), a leader in ...
UiPath's latest product session was billed as an investor briefing, but the most consequential announcement was a pivot in who - or what - the platform is actually built for. Most enterprise AI ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced a new security automation capability, built in collaboration with Microsoft, to help ...
At-home gut health tests use DNA or RNA sequencing from a stool sample. Testing your gut health cannot replace an official diagnosis from a doctor. Your results may provide insights into gut ...
UiPath stock was falling early Thursday after its fourth-quarter earnings. A forecast of slower revenue growth in its current fiscal year punctured hopes the automation-software company will emerge as ...
UiPath PATH0.98%increase; up pointing triangle reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results